In 2019, Chicago Public Schools (CPS) filed a class action complaint in the multi-district opioid litigation underway in federal court in Cleveland, Ohio, seeking damages for expenses related to special education, addiction counseling, campus security and employee health insurance inflicted on public schools by the companies that created the opioid epidemic.
Along with public school districts all over the country, CPS is experiencing unprecedented challenges and costs resulting from the impact of the nationwide opioid epidemic on its students and employees. Studies show that children born to opioid-addicted mothers experience learning and behavioral challenges throughout their lives, and independent public schools like CPS must provide the extra resources needed for their education.
CPS’s roughly 200-page complaint appears to be one of the most detailed lawsuits to argue that reckless sales of opioids ultimately saddled school systems with staggering financial burdens. You can read a copy of the complaint here.
Since CPS filed its class action complaint, a coalition of public school districts has expanded to include both large and small districts, from both urban and rural areas, and from different parts of the country. These public school districts have filed claims in the related Purdue Pharma and Rochester Drug Co-operative bankruptcies, and are preparing to file claims in other bankruptcy proceedings involving entities responsible for the opioid epidemic. School districts interested in finding out more about this effort can do so by contacting us here and by emailing email@example.com. The deadlines to file proof of claim forms are strict, so interested school districts should contact us as soon as possible.